Microglia and neuropathic pain

GLIA

Volumn 57, Issue 14, 2009, Pages 1469-1479

  Kazuhide, Inoue ^a   Makoto, Tsuda ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Chemokine receptors; Cytokines; Microglia; Neuropathic pain; Protein kinases; Purinergic receptors

Indexed keywords

A 438079; A 740003; ANTISENSE OLIGONUCLEOTIDE; BUPIVACAINE; CANGRELOR; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; CANNABINOID RECEPTOR AGONIST; CELL SURFACE RECEPTOR; CHEMOKINE; CLOPIDOGREL; FIBRONECTIN RECEPTOR; FRACTALKINE; GELATINASE B; LIDOCAINE; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MRS 2395; PURINERGIC P2X RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR P2X12 BLOCKING AGENT; PURINERGIC RECEPTOR P2X7 BLOCKING AGENT; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4 BLOCKING AGENT; UNCLASSIFIED DRUG;

ALLODYNIA; CELL COUNT; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; NERVE CELL STIMULATION; NERVE INJURY; NEUROMODULATION; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE DRUG DOSE; SPINAL CORD DORSAL HORN; SYNAPTIC TRANSMISSION;

ANIMALS; CENTRAL NERVOUS SYSTEM; MICROGLIA; MODELS, NEUROLOGICAL; PAIN;

EID: 70450212126     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20871     Document Type: Review

References (128)

1. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ. 2003. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 100:7947-7952. (Pubitemid 36760075)
2. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. 2007. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10:1538-1543. (Pubitemid 350175883)
3. Akira S, Takeda K. 2004. Toll-like receptor signaling. Nat Rev Immunol 4:499-511.
4. Baron R. 2006. Mechanisms of disease: Neuropathic pain - A clinical perspective. Nat Clin Pract Neurol 2:95-106. (Pubitemid 43210250)
5. Beggs S, Salter MW. 2007. Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury. Brain Behav Immun 21:624-633. (Pubitemid 46829774)
6. Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, Costa B. 2008. Glial TLR4 receptor as new target to treat neuropathic pain: Efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 56:1312-1319.
7. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW. 2002. Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis. Brain 125 (Part 6):1297-1308. (Pubitemid 34587139)
8. Burnstock G. 2008. Purinergic signaling and disorders of the central nervous system. Nat Rev Drug Discov 7:575-590. (Pubitemid 351927723)
9. Chattopadhyay S, Myers RR, Janes J, Shubayev V. 2007. Cytokine regulation of MMP-9 in peripheral glia: Implications for pathological processes and pain in injured nerve. Brain Behav Immun 21:561-568. (Pubitemid 46829772)
10. Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P, Egerton J, Murfin M, Richardson J, Peck WL, et al. 2005. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114:386-396. (Pubitemid 40385877)
11. Choi Y, Kim HS, Shin KY, Kim EM, Kim M, Park CH, Jeong YH, Yoo J, Lee JP, Chang KA, Kim S, Suh YH. 2007. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacol 32:2393-2404. (Pubitemid 47587688)
12. Clark AK, Yip PK, Grist J, Gentry C, Staniland AA, Marchand F, Dehvari M, Wotherspoon G, Winter J, Ullah J, Bevan S, Malcangio M. 2007. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci USA 104:10655-10660. (Pubitemid 47185720)
13. Colburn RW, DeLeo JA, Rickman AJ, Yeager MP, Kwon P, Hickey WF. 1997. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 79:163-175. (Pubitemid 27502035)
14. Colburn RW, Rickman AJ, DeLeo JA. 1999. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 157:289-304. (Pubitemid 29260737)
15. Combs CK, Johnson DE, Cannady SB, Lehman TM, Landreth GE. 1999. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J Neurosci 19:928-939.
16. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y. 2005. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017-1021. (Pubitemid 43093974)
17. Coyle DE. 1998. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 23:75-83.
18. Dansereau MA, Gosselin RD, Pohl M, Pommier B, Mechighel P, Mauborgne A, Rostene W, Kitabgi P, Beaudet N, Sarret P, Melik-Parsadaniantz S. 2008. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem 106:757-769.
19. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB. 2005. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752-758. (Pubitemid 43085841)
20. DeLeo JA, Yezierski RP. 2001. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90:1-6.
21. Echeverry S, Shi XQ, Zhang J. 2008. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 135:37-47. (Pubitemid 351193080)
22. Eriksson NP, Persson JK, Svensson M, Arvidsson J, Molander C, Aldskogius H. 1993. A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat. Exp Brain Res 96:19-27. (Pubitemid 23332175)
23. Gehrmann J, Banati RB. 1995. Microglial turnover in the injured CNS: Activated microglia undergo delayed DNA fragmentation following peripheral nerve injury. J Neuropathol Exp Neurol 54:680-688.
24. Gonzalez JC, Egea J, Del Carmen Godino M, Fernandez-Gomez FJ, Sanchez-Prieto J, Gandia L, Garcia AG, Jordan J, Hernandez-Guijo JM. 2007. Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons. Eur J Neurosci 26:2481-2495. (Pubitemid 350050444)
25. Gosselin RD, Varela C, Banisadr G, Mechighel P, Rostene W, Kitabgi P, Melik-Parsadaniantz S. 2005. Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem 95:1023-1034. (Pubitemid 41713487)
26. Griffin RS, Costigan M, Brenner GJ, Ma CH, Schulz J, Moss A, Allchorne AJ, Stahl GL, Woolf CJ. 2007. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J Neurosci 27:8699-8708. (Pubitemid 47254273)
27. Gu YW, Su DS, Tian J, Wang XR. 2008. Attenuating phosphorylation of p38 MAPK in the activated microglia: A new mechanism for intrathecal lidocaine reversing tactile allodynia following chronic constriction injury in rats. Neurosci Lett 431:129-134.
28. Guindon J, Hohmann AG. 2008. Cannabinoid CB2 receptors: A therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 153:319-334.
29. Guo LH, Schluesener HJ. 2007. The innate immunity of the central nervous system in chronic pain: The role of Toll-like receptors. Cell Mol Life Sci 64:1128-1136. (Pubitemid 46684548)
30. Hains BC, Waxman SG. 2006. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 26:4308-4317. (Pubitemid 44315390)
31. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L. 1998. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 95:10896-10901. (Pubitemid 28413165)
32. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D. 2006. The P2Y(12) receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9:1512-1519. (Pubitemid 44862659)
33. Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, Inoue K, Kohsaka S. 2001. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci 21:1975-1982. (Pubitemid 32221381)
34. Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, Zhong C, Gauvin DM, Chandran P, Harris R, Medrano AP, Carroll W, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF. 2006. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}- 2,2-dimethylpropyl)-2-(3, 4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 319:1376-1385. (Pubitemid 44776486)
35. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Meehoulam R, Pertwee RG. 2002. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
36. Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, Sholar PW, Patel SJ, Crysdale NY, Harrison JA, Maier SF, Rice KC, Watkins LR. 2008. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: Involvement of toll-like receptor 4 (TLR4). Eur J Neurosci 28:20-29.
37. Ikeda H, Tsuda M, Inoue K, Murase K. 2007. Long-term potentiation of neuronal excitation by neuron-glia interactions in the rat spinal dorsal horn. Eur J Neurosci 25:1297-1306. (Pubitemid 46568758)
38. Inoue K. 2002. Microglial activation by purines and pyrimidines. Glia 40:156-163.
39. Inoue K. 2006. The function of microglia through purinergic receptors: Neuropathic pain and cytokine release. Pharmacol Ther 109:210-226. (Pubitemid 41740822)
40. Inoue K, Koizumi S, Tsuda M. 2007. The role of nucleotides in the neuron-glia communication responsible for the brain functions. J Neurochem 102:1447-1458. (Pubitemid 47256211)
41. Irie O, Kosaka T, Ehara T, Yokokawa F, Kanazawa T, Hirao H, Iwasaki A, Sakaki J, Teno N, Hitomi Y, Iwasaki G, Fukaya H, Nonomura K, Tanabe K, Koizumi S, Uchiyama N, Bevan SJ, Malcangio M, Gentry C, Fox AJ, Yaqoob M, Culshaw AJ, Allan H. 2008. Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain. J Med Chem 51:5502-5505.
42. Ito T, Ohtori S, Inoue G, Koshi T, Doya H, Ozawa T, Saito T, Moriya H, Takahashi K. 2007. Glial phosphorylated p38 MAP kinase mediates pain in a rat model of lumbar disc herniation and induces motor dysfunction in a rat model of lumbar spinal canal stenosis. Spine 32:159-167. (Pubitemid 46105802)
43. Ji RR, Kawasaki Y, Zhuang ZY, Wen YR, Decosterd I. 2006. Possible role of spinal astrocytes in maintaining chronic pain sensitization: Review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol 2:259-269. (Pubitemid 47074743)
44. Ji RR, Suter MR. 2007. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 3:33
45. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. 2003. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23:4017-4022.
46. Katsura H, Obata K, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K, Dai Y, Fukuoka T, Sakagami M, Noguchi K. 2008. Transforming growth factor-activated kinase 1 induced in spinal astrocytes contributes to mechanical hypersensitivity after nerve injury. Glia 56:723-733.
47. Katsura H, Obata K, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, Fukuoka T, Sakagami M, Noguchi K. 2006. Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J Neurosci 26:8680-8690. (Pubitemid 44319403)
48. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, Ji RR. 2008a. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14:331-336. (Pubitemid 351347915)
49. Kawasaki Y, Zhang L, Cheng JK, Ji RR. 2008b. Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 28:5189-5194.
50. Keller AF, Beggs S, Salter MW, De Koninck Y. 2007. Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain. Mol Pain 3:27 (Pubitemid 350182638)
51. Khakh BS, North RA. 2006. P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:527-532.
52. Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, Choi SY, Park K, Kim JS, Akira S, Na HS, Oh SB, Lee SJ. 2007. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 282:14975-14983. (Pubitemid 47093373)
53. Kim HS, Suh YH. 2009. Minocycline and neurodegenerative diseases. Behav Brain Res 196:168-179.
54. Kobayashi K, Yamanaka H, Fukuoka T, Dai Y, Obata K, Noguchi K. 2008. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J Neurosci 28:2892-2902.
55. Koriyama Y, Chiba K, Mohri T. 2003. Propentofylline protects beta-amyloid protein-induced apoptosis in cultured rat hippocampal neurons. Eur J Pharmacol 458:235-241. (Pubitemid 36009462)
56. Koriyama Y, Yamazaki M, Chiba K, Mohri T. 2000. Evaluation of neurotoxicity of alzheimer's amyloid beta protein (beta42) in cultured hippocampal cells and its prevention by propentofylline. Jpn J Pharmacol 82:301-306. (Pubitemid 30301569)
57. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
58. Lindia JA, McGowan E, Jochnowitz N, Abbadie C. 2005. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain 6:434-438. (Pubitemid 40922694)
59. Liu L, Rudin M, Kozlova EN. 2000. Glial cell proliferation in the spinal cord after dorsal rhizotomy or sciatic nerve transection in the adult rat. Exp Brain Res 131:64-73. (Pubitemid 30137817)
60. Marchand F, Perretti M, McMahon SB. 2005. Role of the immune system in chronic pain. Nat Rev Neurosci 6:521-532. (Pubitemid 40942819)
61. McGaraughty S, Chu KL, Namovic MT, Donnelly-Roberts DL, Harris RR, Zhang XF, Shieh CC, Wismer CT, Zhu CZ, Gauvin DM, Fabiyi AC, Honore P, Gregg RJ, Kort ME, Nelson DW, Carroll WA, Marsh K, Faltynek CR, Jarvis MF. 2007. P2X7-related modulation of pathological nociception in rats. Neuroscience 146:1817-1828. (Pubitemid 46783230)
62. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, Tracey K, Martin D, Maier SF, Watkins LR. 2003. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23:1026-1040. (Pubitemid 36206195)
63. Milligan ED, Zapata V, Chacur M, Schoeniger D, Biedenkapp J, O'Connor KA, Verge GM, Chapman G, Green P, Foster AC, Naeve GS, Maier SF, Watkins LR. 2004. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 20:2294-2302. (Pubitemid 39472392)
64. Moore KJ, El Khoury J, Medeiros LA, Terada K, Geula C, Luster AD, Freeman MW. 2002. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem 277:47373-47379. (Pubitemid 36163374)
65. Moss A, Beggs S, Vega-Avelaira D, Costigan M, Hathway GJ, Salter MW, Fitzgerald M. 2007. Spinal microglia and neuropathic pain in young rats. Pain 128:215-224. (Pubitemid 46367416)
66. Nakajima K, Kohsaka S. 2001. Microglia: Activation and their significance in the central nervous system. J Biochem (Tokyo) 130:169-175. (Pubitemid 32785862)
67. Narita M, Yoshida T, Nakajima M, Narita M, Miyatake M, Takagi T, Yajima Y, Suzuki T. 2006. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J Neurochem 97:1337-1348. (Pubitemid 43725573)
68. Nasu-Tada K, Koizumi S, Tsuda M, Kunifusa E, Inoue K. 2006. Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X(4), a key molecule for mechanical allodynia. Glia 53:769-775.
69. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318. (Pubitemid 40746128)
70. Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A, Satoh M. 1998. Localization of fractalkine and CX3CR1 mRNAs in rat brain: Does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429:167-172.
71. Obata K, Katsura H, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K, Dai Y, Fukuoka T, Akira S, Noguchi K. 2008. Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J Neurochem 105:2249-2259. (Pubitemid 351782279)
72. Obata K, Katsura H, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, Fukuoka T, Noguchi K. 2007. Roles of extracellular signal-regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain. J Neurochem 102:1569-1584. (Pubitemid 47256198)
73. Peters CM, Jimenez-Andrade JM, Jonas BM, Sevcik MA, Koewler NJ, Ghilardi JR, Wong GY, Mantyh PW. 2007. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol 203:42-54.
74. Piao ZG, Cho IH, Park CK, Hong JP, Choi SY, Lee SJ, Lee S, Park K, Kim JS, Oh SB. 2006. Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain 121:219-231.
75. Qureshi OS, Paramasivam A, Yu JC, Murrell-Lagnado RD. 2007. Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J Cell Sci 120 (Part 21):3838-3849. (Pubitemid 350187365)
76. Raghavendra V, Tanga F, DeLeo JA. 2003. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306:624-630. (Pubitemid 36886161)
77. Raivich G, Bohatschek M, Kloss C, Werner A, Jones LL, Kreutzberg GW. 1999. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30:77-105. (Pubitemid 29331517)
78. Reeve AJ, Patel S, Fox A, Walker K, Urban L. 2000. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 4:247-257.
79. Romero-Sandoval A, Nutile-McMenemy N, DeLeo JA. 2008. Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology 108:722-734.
80. Salter MW, Kalia LV. 2004. Src kinases: A hub for NMDA receptor regulation. Nat Rev Neurosci 5:317-328. (Pubitemid 38478658)
81. Schafers M, Svensson CI, Sommer C, Sorkin LS. 2003. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 23:2517-2521. (Pubitemid 36418584)
82. Schulz J, Woolf CJ. 2002. Can we conquer pain? Nat Neurosci 5 Suppl: 1062-1067.
83. Schulz J, Woolf CJ. 2007. The neuropathic pain triad: Neurons, immune cells and glia. Nat Neurosci 10:1361-1368.
84. Sondag CM, Combs CK. 2004. Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells. J Biol Chem 279:14456-14463.
85. Stoll G, Jander S. 1999. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 58:233-247. (Pubitemid 29193056)
86. Stuesse SL, Cruce WL, Lovell JA, McBurney DL, Crisp T. 2000. Microglial proliferation in the spinal cord of aged rats with a sciatic nerve injury. Neurosci Lett 287:121-124. (Pubitemid 30353062)
87. Suter MR, Wen YR, Decosterd I, Ji RR. 2007. Do glial cells control pain? Neuron Glia Biol 3:255-268.
88. Suzuki T, Hide I, Ido K, Kohsaka S, Inoue K, Nakata Y. 2004. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 24:1-7. (Pubitemid 38181664)
89. Sweitzer SM, Schubert P, DeLeo JA. 2001. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 297:1210-1217. (Pubitemid 32472523)
90. Sweitzer SM, White KA, Dutta C, DeLeo JA. 2002. The differential role of spinal MHC class II, cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents. J Neuroimmunol 125:82-93. (Pubitemid 34327457)
91. Tan J, Town T, Mullan M. 2000. CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J Biol Chem 275:37224-37231. (Pubitemid 32002143)
92. Tanaka T, Minami M, Nakagawa T, Satoh M. 2004. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: Possible involvement in the development of neuropathic pain. Neurosci Res 48:463-469. (Pubitemid 38369344)
93. Tanga FY, Nutile-McMenemy N, DeLeo JA. 2005. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA 102:5856-5861. (Pubitemid 40559649)
94. Tanga FY, Raghavendra V, DeLeo JA. 2004. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 45:397-407. (Pubitemid 38625630)
95. Tawfik VL, Nutile-McMenemy N, Lacroix-Fralish ML, Deleo JA. 2007. Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury. Brain Behav Immun 21:238-246. (Pubitemid 46038912)
96. Terayama R, Omura S, Fujisawa N, Yamaai T, Ichikawa H, Sugimoto T. 2008. Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury. Neuroscience 153:1245-1255.
97. Thacker MA, Clark AK, Bishop T, Grist J, Yip PK, Moon LD, Thompson SW, Marchand F, McMahon SB. 2009. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 13:263-272.
98. Tozaki-Saitoh H, Tsuda M, Miyata H, Ueda K, Kohsaka S, Inoue K. 2008. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J Neurosci 28:4949-4956.
99. Tsuda M, Inoue K, Salter MW. 2005. Neuropathic pain and spinal microglia: A big problem from molecules in ''small'' glia. Trends Neurosci 28:101-107.
100. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K. 2004. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45:89-95. (Pubitemid 38076231)
101. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K. 2003. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424:778-783. (Pubitemid 37021707)
102. Tsuda M, Toyomitsu E, Komatsu T, Masuda T, Kunifusa E, Nasu-Tada K, Koizumi S, Yamamoto K, Ando J, Inoue K. 2008a. Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia 56:579-585.
103. Tsuda M, Tozaki-Saitoh H, Masuda T, Toyomitsu E, Tezuka T, Yamamoto T, Inoue K. 2008b. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 56:50-58. (Pubitemid 350172730)
104. Tsuda M, Ueno H, Kataoka A, Tozaki-Saitoh H, Inoue K. 2008c. Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. Glia 56:378-386.
105. Twining CM, Sloane EM, Schoeniger DK, Milligan ED, Martin D, Marsh H, Maier SF, Watkins LR. 2005. Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization. J Pain 6:174-183. (Pubitemid 40365021)
106. Vega-Avelaira D, Moss A, Fitzgerald M. 2007. Age-related changes in the spinal cord microglial and astrocytic response profile to nerve injury. Brain Behav Immun 21:617-623. (Pubitemid 46829770)
107. Verge GM, Milligan ED, Maier SF, Watkins LR, Naeve GS, Foster AC. 2004. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 20:1150-1160.
108. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. 2003. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692-8700. (Pubitemid 37176649)
109. Wang S, Cheng Q, Malik S, Yang J. 2000. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 292:497-504. (Pubitemid 30067411)
110. Watkins LR, Hutchinson MR, Johnston IN, Maier SF. 2005. Glia: Novel counter-regulators of opioid analgesia. Trends Neurosci 28:661-669.
111. Watkins LR, Hutchinson MR, Milligan ED, Maier SF. 2007. "Listening" and "talking" to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev 56:148-169.
112. Watkins LR, Milligan ED, Maier SF. 2001. Glial activation: A driving force for pathological pain. Trends Neurosci 24:450-455.
113. Wen YR, Suter MR, Kawasaki Y, Huang J, Pertin M, Kohno T, Berde CB, Decosterd I, Ji RR. 2007. Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen- activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology 107:312-321. (Pubitemid 47196496)
114. White FA, Sun J, Waters SM, Ma C, Ren D, Ripsch M, Steflik J, Cortright DN, Lamotte RH, Miller RJ. 2005. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci USA 102:14092-14097. (Pubitemid 41377708)
115. Winkelstein BA, DeLeo JA. 2002. Nerve root injury severity differentially modulates spinal glial activation in a rat lumbar radiculopathy model: Considerations for persistent pain. Brain Res 956:294-301.
116. Woolf CJ, Mannion RJ. 1999. Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet 353:1959-1964. (Pubitemid 29255720)
117. Woolf CJ, Salter MW. 2000. Neuronal plasticity: Increasing the gain in pain. Science 288:1765-1769.
118. Xu JT, Xin WJ, Wei XH, Wu CY, Ge YX, Liu YL, Zang Y, Zhang T, Li YY, Liu XG. 2007. p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp Neurol 204:355-365. (Pubitemid 46330283)
119. Yamamoto W, Mikami T, Iwamura H. 2008. Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain. Eur J Pharmacol 583:56-61.
120. Ye Y, Jackson K, Houslay MD, Chandler LJ, O'Donnell JM. 2001. Development of rolipram-sensitive, cyclic AMP phosphodiesterase (PDE4) in rat primary neuronal cultures. Brain Res Dev Brain Res 130:115-121. (Pubitemid 32830979)
121. Zhang J, De Koninck Y. 2006. Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J Neurochem 97:772-783.
122. Zhang J, Hoffert C, Vu HK, Groblewski T, Ahmad S, O'Donnell D. 2003. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci 17:2750-2754. (Pubitemid 36819300)
123. Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S. 2007. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 27:12396-12406. (Pubitemid 350085465)
124. Zhang RX, Liu B, Wang L, Ren K, Qiao JT, Berman BM, Lao L. 2005. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 118:125-136. (Pubitemid 41566591)
125. Zhao P, Waxman SG, Hains BC. 2007. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J Neurosci 27:2357-2368. (Pubitemid 46340975)
126. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. 2005. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114:149-159. (Pubitemid 40279096)
127. Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR. 2007. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21:642-651. (Pubitemid 46830963)
128. Zhuang ZY, Wen YR, Zhang DR, Borsello T, Bonny C, Strichartz GR, Decosterd I, Ji RR. 2006. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: Respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 26:3551-3560.